Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MYADM antisense RNA 1 (MYADM-AS1)
- Target
- MYADM-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
MYADM antisense RNA 1 (MYADM-AS1) is a long non-coding RNA transcribed antisense to the MYADM gene, belonging to the lncRNA class. Antisense RNAs such as MYADM-AS1 typically regulate gene expression by interacting with messenger RNAs of their sense counterparts, potentially affecting transcription, mRNA stability, and translation. MYADM-AS1 is not a protein, receptor, enzyme, or classical drug target, and no known drugs or therapeutic interventions directly interact with it[1][3][5]. There is no evidence currently linking MYADM-AS1 directly to disease processes, biomarker roles, or safety concerns in therapeutic development.
- Other names
- MYADM-AS1HGNC:40384NCBI Gene:105372457Ensembl:ENSG00000228323
02
Mechanism of action
No drugs; but generally, antisense RNAs regulate gene expression by binding complementary mRNA and inhibiting translation or inducing degradation[5]
03
Biological functions
Regulation of gene expression (by antisense interaction)
04
Disease associations
Unknown (no evidence in current search results of a direct role in disease)
Beyond the preview
Go deeper on MYADM antisense RNA 1 (MYADM-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MYADM antisense RNA 1 (MYADM-AS1).